Midline Catheter and Its Impact on Central Lines Removal in ICU (MIDREA)
Sponsor: Centre Hospitalier Departemental Vendee
Terminated
recruitment problem
Other terminated trials from Centre Hospitalier Departemental Vendee
- Acromioclavicular Arthropathy · Phase NA · Jun 2025
- Cognitive Impairment · Phase NA · Apr 2023
- Polyps of Colon · Phase NA · Jul 2022
- Acute Kidney Injury · Phase NA · Apr 2022
- Acute Care Unit · Phase NA · Mar 2022
See all terminations from Centre Hospitalier Departemental Vendee
This NA trial investigates Vascular Access Device and is currently terminated or withdrawn. Centre Hospitalier Departemental Vendee leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2023 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Apr 2022 — Apr 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Apr 2021 — Apr 2022 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Feb 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Feb 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Departemental Vendee
For direct contact, visit the study record on ClinicalTrials.gov .